🇺🇸 FDA

Intelligence · Patent portfolio

Chinese Academy of Patents

Full USPTO pharma patent portfolio for Chinese Academy of — grant dates, expiration, and drug cross-links.

Patents
335
Expiring ≤24m
3

Quick answer

Chinese Academy of has 335 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months — use filters for patent-cliff planning.

Page 6 of 7

  1. US 9609883

    Method for producing wheat glutamine peptide

    Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9593151

    Use of fusion protein

    Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9574012

    AGR2 blocking antibody and use thereof

    Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9545443

    Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

    Expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9517262

    Vaccine injection, preparation method and use thereof

    Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9493552

    Therapeutic biologic for treatment of hepatocellular carcinoma

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9493496

    Algin oligosaccharides and the derivatives thereof as well as the manufacture and the use of the same

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9463220

    Method for inducing twin calving

    Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9410969

    Method for determining and treating amyotrophic lateral sclerosis

    Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9394359

    Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

    Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9320774

    Method for reducing radio-resistance of prostate cancer cells and/or treating prostate cancer

    Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9272978

    Hydroxy acid ester compound of substituted phenol, preparation method and medical use thereof

    Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9266813

    Stilbenoid compound as inhibitor for squamous carcinoma and hepatoma and uses thereof

    Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9259453

    Use of salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases

    Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9243009

    Phosphate ester compound of hydroxy acid substituted phenol ester, preparation method and medical use thereof

    Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9211244

    Method for anti-skin aging using caffeamide derivative

    Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9205073

    Method for treating virus infection using derivative of aniline

    Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9200301

    Marine streptomyces, pyranosesquiterpene compound, as well as preparation method and applications thereof

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9186421

    Establishment of rhesus monkey model of autoimmunity type 1 diabetes

    Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9167841

    Tangerine peel extract and its preparation and application

    Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9139620

    Feline morbillivirus and uses thereof

    Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9115150

    Camptothecin compound containing stable 7-membered lactone ring, preparation method and use

    Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9085598

    Compounds targeting the cell invasion protein complex, their pharmaceutical compositions and methods of use thereof

    Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9072770

    Aqueous extracts of Anoectochilus spp. kinsenoside and pharmaceutical compositions useful for hepatoprotection

    Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9044444

    Method for improving skin appearance and reducing hair loss

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9045437

    2-aryl-4-quinazolinones and their pharmaceutical compositions

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9029326

    Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9029394

    2-phenyl-4-quinolones as anticancer agents

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9023809

    Phenylalanine dipeptide derivatives, compositions and use thereof

    Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9023867

    Hydrophilic derivatives of 2-selenophene-4-quinolones as anticancer agents

    Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9023866

    2-selenophene-4-quinolones as anticancer agents

    Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9018251

    Method for treating brain cancer or reducing temozolomide-resistance of brain cancer cells

    Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9011925

    Method for preparing polysaccharide nanocomposite particles and uses of the same

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9006239

    2-aryl-4-quinazolinones and their pharmaceutical compositions

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8980887

    2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, preparation methods and uses thereof

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8969406

    Use of compound for inhibiting glutathione s-transferase omega 1 activity and method for synthesizing the same

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8946384

    Polypeptide TF1 for inhibiting type 2 Shiga toxin activity, encoding gene for same and use thereof

    Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8940685

    Method for preparing active peptides from corn germ proteins

    Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8884007

    Hexenone compounds and medical use thereof

    Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8859527

    Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treatment of cancer thereof

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8852576

    Modified sodium iodide symporter proteins and uses thereof

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8853271

    Method for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen using tormentic acid

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8846627

    Method for treatment of malaria

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8846752

    Isoflavone fatty acid ester derivatives, preparation method and pharmaceutical uses thereof

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8835405

    Inhibiting arthritis via injection of synergistic combination of hyaluronic acid and vitamin C and/or vitamin E

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8821880

    Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8815240

    Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

    Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8809319

    Substituted 8-oxa-10,11-dihydroimidazo[2,3-a]bicyclo[3.2.1]oct-3-enes and use thereof as an insecticide

    Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Chinese Academy of have?

335 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Chinese Academy of patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.